Regorafenib is a targeted therapy drug used for the treatment of metastatic colorectal cancer (mCRC). It is a multi-kinase inhibitor that works by blocking several proteins that are involved in the growth and spread of cancer cells. This drug works by inhibiting enzymes that are involved in the growth and spread of cancer cells, such as VEGF and VEGFR. As a result, it slows down the growth and spread of cancer cells, thus providing relief from symptoms associated with mCRC. Regorafenib is generally used in combination with other drugs that can help to further slow down cancer cell growth and spread. Common side effects of regorafenib include fatigue, diarrhea, hand-foot syndrome, hypertension, and appetite loss.
Regorafenib, marketed under the brand name Stivarga, is a medication used to treat specific types of advanced cancers. Here's a breakdown of its mechanism of action and applications:
Type of Drug:
- Kinase inhibitor: Regorafenib belongs to a class of drugs called kinase inhibitors, which target specific enzymes known as kinases [1, 2]. Kinases play a crucial role in cell signaling pathways that regulate cell growth and survival. By blocking these enzymes, Regorafenib can hinder the growth and spread of cancer cells [1, 2].
How it Works:
- Regorafenib targets multiple kinases involved in different cellular processes that promote cancer progression. These include:
- Angiogenesis (formation of new blood vessels that tumors need to grow) [1].
- Cell division and proliferation [2].
- Tumor microenvironment (the surrounding tissue that supports tumor growth) [2].
Conditions Treated:
- Metastatic colorectal cancer (CRC): This is the most common use of Regorafenib. It's typically used after other treatments for advanced CRC have failed [1, 2].
- Other cancers: Regorafenib is also being investigated for its potential effectiveness in treating other types of advanced cancers, such as gastrointestinal stromal tumors (GIST) and hepatocellular carcinoma (liver cancer) [2].
Benefits:
- May help slow the progression of metastatic colorectal cancer, potentially improving survival rates [1, 2].
- May be effective in some patients with other advanced cancers [2].
Important Considerations:
- Regorafenib is typically used when other treatments haven't been successful. It can cause significant side effects, so your doctor will carefully assess your individual situation and weigh the benefits against the risks [1, 2].
- Common side effects include hand-foot syndrome (rash and swelling on palms and soles), fatigue, diarrhea, mouth sores, and high blood pressure [2].
- Regular monitoring by your doctor is necessary while taking Regorafenib [2].